Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Eur Rev Med Pharmacol Sci ; 19(7): 1285-90, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25912591

ABSTRACT

OBJECTIVE: To investigate the cardioprotective effects of isoflurane and exendin-4 against myocardial ischemia/reperfusion injury and the signaling pathways through which these effects are mediated. MATERIALS AND METHODS: For infarct size measurements, anesthetized mice were subjected to 30 min of coronary artery occlusion followed by 2 h of reperfusion. Wild-type or caveolin-3 knockout mice received isoflurane, exendin-4, or isoflurane with exendin-4 before ischemia index determination. Caveolin-3 expression in the heart was measured by immunoblotting. RESULTS: Myocardial infarct size was smaller in the isoflurane- [1.0 minimum alveolar concentration (MAC)] or exendin-4- (30 ng/kg i.v.) treated groups than the controls. Infarct size was not affected by isoflurane at 0.5 MAC or 3 ng/kg i.v. exendin-4, but the combination of these treatments reduced infarct size. Pharmacological preconditioning (isoflurane at 1.0 MAC, 30 ng/kg i.v. exendin-4, or isoflurane at 0.5 MAC with 3 ng/kg i.v. exendin-4) increased caveolin-3 protein expression in the heart after infarct induction. The cardioprotective effects of isoflurane, exendin-4, and isoflurane with exendin-4 were abolished in caveolin-3 knockout mice. CONCLUSIONS: The combination of isoflurane and exendin-4 reduced infarct size, but it was not more effective than either agent alone, and the cardioprotective effects of these agents are mediated by caveolin-3 expression.


Subject(s)
Caveolin 3/biosynthesis , Glucagon-Like Peptide-1 Receptor/agonists , Ischemic Preconditioning, Myocardial/methods , Isoflurane/administration & dosage , Myocardial Infarction/prevention & control , Peptides/administration & dosage , Venoms/administration & dosage , Anesthetics, Inhalation/administration & dosage , Animals , Drug Therapy, Combination , Exenatide , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocardial Infarction/metabolism , Myocardial Reperfusion Injury/metabolism , Myocardial Reperfusion Injury/prevention & control
2.
Minerva Anestesiol ; 81(4): 362-8, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25220550

ABSTRACT

BACKGROUND: Postoperative opioid analgesia increases the incidence of postoperative nausea and vomiting (PONV). We investigated whether a combination of the neurokinin-1 antagonist aprepitant and dexamethasone decreases PONV incidence compared with dexamethasone alone in high-risk patients receiving continuous epidural fentanyl. METHODS: Sixty nonsmoking female patients scheduled for elective knee osteoarthritis surgery were randomly allocated to receive oral aprepitant 80 mg (aprepitant+dexamethasone group, N.=30) 2 h before anesthesia induction or no oral aprepitant (dexamethasone group, N.=30). All patients received intravenous dexamethasone 8 mg immediately before anesthesia induction. Anesthesia was maintained with remifentanil and sevoflurane. Continuous infusion of epidural analgesia, including fentanyl, was provided during and after surgery. We assessed complete response (no PONV and no rescue antiemetic use), incidence of nausea and vomiting, nausea severity scale, vomiting frequency, rescue antiemetic use, and postoperative pain at 2 and 24 h after surgery. RESULTS: The cumulative incidence of vomiting at 24 h was 3% in the aprepitant+dexamethasone group and 27% in the dexamethasone group (P=0.011). The incidence and frequency of vomiting in the late postoperative period was also significantly lower in the aprepitant+dexamethasone group than in the dexamethasone group. However, there were no significant group differences in the proportion of patients who experienced a complete response, the incidence and severity of nausea, and rescue antiemetic use at 24 h. CONCLUSION: The combination of aprepitant and dexamethasone was more effective in preventing postoperative vomiting compared with dexamethasone alone in patients at high-risk of PONV from continuous epidural fentanyl analgesia.


Subject(s)
Analgesics, Opioid/adverse effects , Antiemetics/therapeutic use , Dexamethasone/therapeutic use , Fentanyl/adverse effects , Morpholines/therapeutic use , Postoperative Nausea and Vomiting/chemically induced , Postoperative Nausea and Vomiting/prevention & control , Aged , Analgesia, Epidural/adverse effects , Aprepitant , Female , Humans , Knee/surgery , Middle Aged , Osteoarthritis
3.
Anaesthesia ; 66(6): 515-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21457154

ABSTRACT

Paraneoplastic limbic encephalitis associated with ovarian teratoma has recently been related to the development of antibodies to specific heteromers of the N-methyl-d-aspartate receptor and exhibits various manifestations including psychiatric symptoms, hypoventilation, seizures and derangement of autonomic nervous system function. Although recovery can sometimes occur spontaneously, early tumour resection with immunotherapy facilitates earlier recovery. Herein, we describe anaesthetic management of a 20-year-old woman who developed general convulsions and decreased level of consciousness, whom we suspected of having paraneoplastic limbic encephalitis and was scheduled for left ovarian tumour resection. Anaesthetic management was successful with no complications but the case acts as focus of discussion for the potential interaction of N-methyl-D-aspartate receptors and anaesthetic sensitivity.


Subject(s)
Anesthesia, General/methods , Limbic Encephalitis/etiology , Ovarian Neoplasms/surgery , Receptors, N-Methyl-D-Aspartate/immunology , Teratoma/surgery , Autoantibodies/analysis , Female , Humans , Limbic Encephalitis/immunology , Ovarian Neoplasms/complications , Seizures/etiology , Teratoma/complications , Young Adult
4.
DNA Cell Biol ; 20(4): 189-202, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11403716

ABSTRACT

To characterize interleukin (IL)-5-induced eosinophils, we examined the expression of CD44, very late antigen (VLA)-4, and the IL-5 receptor alpha chain, as well as the levels of eosinophil peroxidase and the generation of superoxide. Eosinophils were prepared from IL-5-transgenic mice, then characterized using electron microscopy to determine their responses to stimuli. Whereas CD44 densities remained almost constant, the level of VLA-4 increased in parallel with eosinophil maturation. Although a subset of IL-5-induced eosinophils with high side scatter recovered from bone marrow and rare ones found in blood recognized hyaluronic acid (HA), most did not have this property. Bone marrow eosinophils with high side scatter and lower density contained eosinophil peroxidase, not only in granules, but also in membranous structures for 30% of this population. This population developed HA-binding ability in response to IL-3, IL-4, IL-5, granulocyte-macrophage colony-stimulating factor, macrophage inflammatory protein (MIP)-2, monocyte chemotactic protein (MCP)-1, eotaxin, nerve growth factor (NGF), and opsonized zymosan (OZ). Peripheral blood eosinophils acquired HA-binding ability in response to the same stimuli, but their responses were less than those of bone marrow eosinophils with high levels of side scatter. However, splenic eosinophils did not respond to these stimuli. Although peripheral blood eosinophils did not proliferate when stimulated by IL-5, these were the only cells that released eosinophil peroxidase in response to IL-4, MIP-2, MCP-1, eotaxin, NGF, and OZ. With the exception of a subset of bone marrow eosinophils, the ability to acquire HA binding, but not the ability to generate superoxide, correlated with eosinophil peroxidase activity and major basic protein accumulation in the granules of maturing cells.


Subject(s)
Chemokines, CC , Eosinophils/cytology , Hyaluronan Receptors/metabolism , Hyaluronic Acid/metabolism , Animals , Blood Cells/cytology , Blood Cells/drug effects , Blood Cells/metabolism , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Cell Adhesion/drug effects , Cell Cycle , Cell Differentiation , Chemokine CCL11 , Cytokines/pharmacology , Eosinophil Peroxidase , Eosinophils/drug effects , Eosinophils/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Interleukin-3/pharmacology , Interleukin-4/pharmacology , Interleukin-5/genetics , Interleukin-5/pharmacology , Interleukin-5/physiology , Mice , Mice, Inbred C3H , Mice, Transgenic , Nerve Growth Factor/pharmacology , Neuraminidase/pharmacology , Opsonin Proteins/pharmacology , Organ Specificity , Peroxidases/metabolism , Recombinant Proteins/pharmacology , Spleen/cytology , Superoxides/metabolism , Zymosan/pharmacology
5.
Bull Tokyo Med Dent Univ ; 22(2): 151-4, 1975 Jun.
Article in English | MEDLINE | ID: mdl-1064485

ABSTRACT

It is said that the Paneth cells are found in the large intestine in a pathological state such as ulcerative colitis or adenoma. We examined the Paneth cells in the adenomas of familial polyposis coli. Nine cases including one case of Gardner's syndrome comprised the material for the examination of the Paneth cells because the caecum was available for the examination. The remaining one case had no Paneth cells. In two cases, the Paneth cells were found among the adenomas in the areas beyond the caecum and the proximal part of the colon ascendens. In one remarkable case, the Paneth cells were found in 43% of the adenomas in the caecum. Seven cases were carcinomas but no Paneth cells were found in or near the carcinoma. In the control cases, which were taken from the resected colon with a disease other than familial polyposis coli, the Paneth cells were found confined to the caecum. We concluded that the distribution of the Paneth cell-bearing adenomas reflects the distribution of the Paneth cells in the normal mucosa of the large intestine and that the Paneth cells in the adenoma may have differentiated in the adenoma.


Subject(s)
Adenoma/pathology , Colonic Neoplasms/pathology , Intestinal Polyps/pathology , Rectal Neoplasms/pathology , Adult , Aged , Epithelial Cells , Epithelium/pathology , Female , Humans , Intestinal Mucosa , Intestine, Large/cytology , Male , Middle Aged
6.
Johns Hopkins Med J ; 136(2): 71-82, 1975 Feb.
Article in English | MEDLINE | ID: mdl-1117595

ABSTRACT

Two hundred and twenty-two patients with Peutz-Jeghers syndrome were ascertained in Japan between 1961 and 1974 through two nationwide surveys, medical literature, and personal examinations. Genetic analysis was made of this group as well as 102 follow-up cases. The average age at diagnosis was 23 in males and 26 in females, with male to female ratio of 1:1.13. Presenting complaints of 170 patients included obstruction (42.8 per cent of patients), abdominal pain (23.4 per cent), rectal bleeding (13.5 per cent), extrusion of polyp (7.2 percent). Diagnosis of 52 patients was based on melanin pigmentation. Intussusception occurred in 46.9 per cent of the patients, most often in the small intestine. Polyps occurred in the stomach in 108 patients (48.6 per cent), small intestine, 142 patients (64 per cent), colon, 118 patients (53.2 per cent) and rectum, 71 patients (32 per cent). Among the 222 patients, cancer was histologically verified in 28. Fifteen early cancers occurred (3 gastric, 8 small intestine, 4 colon), and 11 advanced cancers (3 gastric, 1 small intestine, 6 colon, and 1 both colon and small intestine). Mortality was lower than in patients with familial polyposis coli but higher than in the general population. Conservative surgical management, planned medical follow-up, and the need for a national registration system are stressed.


Subject(s)
Peutz-Jeghers Syndrome/diagnosis , Adolescent , Adult , Aged , Child , Child, Preschool , Colonic Neoplasms/genetics , Duodenal Neoplasms/genetics , Female , Follow-Up Studies , Humans , Ileum , Infant , Intestinal Polyps/genetics , Intestine, Large , Intestine, Small , Jejunum , Male , Middle Aged , Pedigree , Peutz-Jeghers Syndrome/genetics , Peutz-Jeghers Syndrome/surgery , Polyps/genetics , Rectal Neoplasms/genetics , Stomach Neoplasms/genetics
10.
Nihon Ishikai Zasshi ; 59(3): 394-401, 1968 Feb 01.
Article in Japanese | MEDLINE | ID: mdl-5693763
15.
Nihon Rinsho ; 24(7): 1281-6, 1966 Jul.
Article in Japanese | MEDLINE | ID: mdl-6007632
SELECTION OF CITATIONS
SEARCH DETAIL
...